Home LiteratureArticle Details
PMID: 18245257 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains.

Applied and environmental microbiology ·Vol. 74 ·No. 7 ·2008-04-00 ·Pages 2153-60

Coombes BK, Wickham ME, Mascarenhas M, Gruenheid S, Finlay BB, Karmali MA

Abstract

Shiga toxin-producing Escherichia coli (STEC) strains are commensal bacteria in cattle with high potential for environmental and zoonotic transmission to humans. Although O157:H7 is the most common STEC serotype, there is growing concern over the emergence of more than 200 highly virulent non-O157 STEC serotypes that are globally distributed, several of which are associated with outbreaks and/or severe human illness such as hemolytic-uremic syndrome (HUS) and hemorrhagic colitis. At present, the underlying genetic basis of virulence potential in non-O157 STEC is unknown, although horizontal gene transfer and the acquisition of new pathogenicity islands are an expected origin. We used seropathotype classification as a framework to identify genetic elements that distinguish non-O157 STEC strains posing a serious risk to humans from STEC strains that are not associated with severe and epidemic disease. We report the identification of three genomic islands encoding non-LEE effector (nle) genes and 14 individual nle genes in non-O157 STEC strains that correlate independently with outbreak and HUS potential in humans. The implications for transmissible zoonotic spread and public health are discussed. These results and methods offer a molecular risk assessment strategy to rapidly recognize and respond to non-O157 STEC strains from environmental and animal sources that might pose serious public health risks to humans.

MeSH Terms
Animals Colon/microbiology Escherichia coli Infections/diagnosis Genes, Bacterial Genomic Islands/genetics,physiology Hemolytic-Uremic Syndrome/epidemiology,microbiology Humans Public Health Shiga Toxins/biosynthesis Shiga-Toxigenic Escherichia coli/classification,genetics,isolation & purification Virulence Factors/genetics
Chemicals
Shiga Toxins Virulence Factors
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Coombes Brian K
Department of Biochemistry and Biomedical Sciences, McMaster University, Health Sciences Centre 4H17, 1200 Main St. West, Hamilton, Ontario L8N 3Z5, Canada. coombes@mcmaster.ca
Wickham Mark E
Mascarenhas Mariola
Gruenheid Samantha
Finlay B Brett
Karmali Mohamed A
References (40)
40 references, click to expand
  1. Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease.
    J Clin Microbiol. 2003 Nov;41(11):4930-40 PMID: 14605120
  2. Estimating the relative contributions of virulence factors for pathogenic microbes.
    Infect Immun. 2006 Mar;74(3):1500-4 PMID: 16495520
  3. Virulence is positively selected by transmission success between mammalian hosts.
    Curr Biol. 2007 May 1;17(9):783-8 PMID: 17442572
  4. Genome evolution in major Escherichia coli O157:H7 lineages.
    BMC Genomics. 2007 May 16;8:121 PMID: 17506902
  5. Genomic islands in pathogenic and environmental microorganisms.
    Nat Rev Microbiol. 2004 May;2(5):414-24 PMID: 15100694
  6. Diarrheagenic Escherichia coli.
    Clin Microbiol Rev. 1998 Jan;11(1):142-201 PMID: 9457432
  7. Evolution of genomic content in the stepwise emergence of Escherichia coli O157:H7.
    J Bacteriol. 2005 Mar;187(5):1783-91 PMID: 15716450
  8. Dissecting virulence: systematic and functional analyses of a pathogenicity island.
    Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3597-602 PMID: 14988506
  9. Development of a respiratory virus panel test for detection of twenty human respiratory viruses by use of multiplex PCR and a fluid microbead-based assay.
    J Clin Microbiol. 2007 Sep;45(9):2965-70 PMID: 17596360
  10. Non-O157 Shiga toxin-producing Escherichia coli infections in Europe.
    Emerg Infect Dis. 1997 Oct-Dec;3(4):578-9 PMID: 9366613
  11. Complete nucleotide sequence of the prophage VT1-Sakai carrying the Shiga toxin 1 genes of the enterohemorrhagic Escherichia coli O157:H7 strain derived from the Sakai outbreak.
    Gene. 2000 Nov 27;258(1-2):127-39 PMID: 11111050
  12. Characterization of two non-locus of enterocyte effacement-encoded type III-translocated effectors, NleC and NleD, in attaching and effacing pathogens.
    Infect Immun. 2005 Dec;73(12):8411-7 PMID: 16299341
  13. Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves.
    Infect Immun. 1997 May;65(5):1842-8 PMID: 9125570
  14. Identification of enterohemorrhagic Escherichia coli O26:H- genes required for intestinal colonization in calves.
    Infect Immun. 2005 Mar;73(3):1735-43 PMID: 15731074
  15. Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection.
    Infect Immun. 2004 Apr;72(4):2288-302 PMID: 15039354
  16. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.
    J Infect Dis. 1985 May;151(5):775-82 PMID: 3886804
  17. Pathogenicity islands and the evolution of microbes.
    Annu Rev Microbiol. 2000;54:641-79 PMID: 11018140
  18. Citrobacter rodentium virulence in mice associates with bacterial load and the type III effector NleE.
    Microbes Infect. 2007 Mar;9(3):400-7 PMID: 17317262
  19. Identification of four fimbria-encoding genomic islands that are highly specific for verocytotoxin-producing Escherichia coli serotype O157 strains.
    J Clin Microbiol. 2005 Aug;43(8):3840-50 PMID: 16081921
  20. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002.
    J Infect Dis. 2005 Oct 15;192(8):1422-9 PMID: 16170761
  21. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7.
    Nature. 2001 Jan 25;409(6819):529-33 PMID: 11206551
  22. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli.
    Clin Infect Dis. 2006 Dec 15;43(12):1587-95 PMID: 17109294
  23. Intimin facilitates colonization by Escherichia coli O157:H7 in adult ruminants.
    Infect Immun. 2002 May;70(5):2704-7 PMID: 11953416
  24. Waterborne outbreak of gastroenteritis associated with a contaminated municipal water supply, Walkerton, Ontario, May-June 2000.
    Can Commun Dis Rep. 2000 Oct 15;26(20):170-3 PMID: 11211701
  25. Virulence factors in Escherichia coli urinary tract infection.
    Clin Microbiol Rev. 1991 Jan;4(1):80-128 PMID: 1672263
  26. Octamer-based genome scanning distinguishes a unique subpopulation of Escherichia coli O157:H7 strains in cattle.
    Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13288-93 PMID: 10557313
  27. Identification of Escherichia coli O157 : H7 genes influencing colonization of the bovine gastrointestinal tract using signature-tagged mutagenesis.
    Microbiology (Reading). 2004 Nov;150(Pt 11):3631-3645 PMID: 15528651
  28. Genomic variability of O islands encoding tellurite resistance in enterohemorrhagic Escherichia coli O157:H7 isolates.
    J Bacteriol. 2002 Sep;184(17):4690-8 PMID: 12169592
  29. Common themes in the genome strategies of pathogens.
    Curr Opin Genet Dev. 2005 Dec;15(6):584-8 PMID: 16188434
  30. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection.
    J Infect Dis. 2006 Sep 15;194(6):819-27 PMID: 16941350
  31. Infection by Shiga toxin-producing Escherichia coli: an overview.
    Mol Biotechnol. 2004 Feb;26(2):117-22 PMID: 14764937
  32. Future trends and challenges in pathogenomics. A Foresight study.
    EMBO Rep. 2005 Jul;6(7):600-5 PMID: 15995675
  33. Non-toxigenic Escherichia coli O157:H7 strain NCTC12900 causes attaching-effacing lesions and eae-dependent persistence in weaned sheep.
    Int J Med Microbiol. 2003 Aug;293(4):299-308 PMID: 14503794
  34. Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium.
    Infect Immun. 2006 Apr;74(4):2328-37 PMID: 16552063
  35. Evidence for a hybrid genomic island in verocytotoxin-producing Escherichia coli CL3 (serotype O113:H21) containing segments of EDL933 (serotype O157:H7) O islands 122 and 48.
    Infect Immun. 2004 Mar;72(3):1496-503 PMID: 14977955
  36. Genomics and bacterial pathogenesis.
    Emerg Infect Dis. 2000 Sep-Oct;6(5):496-504 PMID: 10998381
  37. An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination.
    Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14941-6 PMID: 16990433
  38. Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7.
    Mol Microbiol. 2004 Mar;51(5):1233-49 PMID: 14982621
  39. Perspective: the problem of non-O157:H7 shiga toxin (Verocytotoxin)-producing Escherichia coli.
    J Infect Dis. 1996 Nov;174(5):1136-9 PMID: 8896525
  40. Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000.
    Emerg Infect Dis. 2003 Jan;9(1):106-8 PMID: 12533290
Article Info
Journal
Applied and environmental microbiology
Abbr.
Appl Environ Microbiol
ISSN
1098-5336
Published
2008-04-00
Epub
2008-00-01
Pages
2153-60
Language
English
Region
United States
NLM ID
7605801
PMCID
PMC2292595
Subset
IM
Grants
Howard Hughes Medical Institute · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com